Narcolepsy Stocks List

Narcolepsy Stocks Recent News

Date Stock Title
Jul 1 TEVA Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings
Jul 1 TEVA Correction: Top Midday Stories: Boeing to Acquire Spirit AeroSystems; Robinhood Acquires Pluto; FTC Probes Teva; BlackRock Acquires Preqin; SCOTUS Grants Trump Some Immunity
Jul 1 TEVA Teva focus of FTC investigation over inhaler patents
Jul 1 JAZZ Is Jazz Pharmaceuticals plc (JAZZ) the Best Pot Stock to Buy Now?
Jun 28 TEVA New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses
Jun 28 NLSP NLS Pharmaceutics looks to raise $0.79M via securities offering
Jun 28 NLSP NLS Pharmaceutics Announces Registered Direct Offering
Jun 27 AVDL Avadel Pharmaceuticals to join Russell 3000 index
Jun 27 AVDL Avadel Pharmaceuticals to Join Russell 3000® Index
Jun 27 NLSP Top Midday Gainers
Jun 27 NLSP NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
Jun 25 JAZZ 3 Cannabis Stocks That Could Make Your Grandchildren Rich
Jun 25 TEVA Teva to pay $750M as part of tax deal with Israel
Jun 25 NLSP Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
Jun 25 HRMY HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
Jun 25 TEVA Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020
Jun 25 ZVRA Zevra Therapeutics Expands Executive Leadership Team
Narcolepsy

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of those affected also experience episodes of sudden loss of muscle strength, known as cataplexy. These experiences can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.The exact cause of narcolepsy is unknown, with potentially several causes. In up to 10% of cases, there is a family history of the disorder. Often, those affected have low levels of the neuropeptide orexin, which may be due to an autoimmune disorder. Trauma, infections, toxins or psychological stress may also play a role. Diagnosis is typically based on the symptoms and sleep studies, after ruling out other potential causes. Excessive daytime sleepiness can also be caused by other sleep disorders such as sleep apnea, major depressive disorder, anemia, heart failure, drinking alcohol and not getting enough sleep. Cataplexy may be mistaken for seizures.While there is no cure, a number of lifestyle changes and medications may help. Lifestyle changes include taking regular short naps and sleep hygiene. Medications used include modafinil, sodium oxybate and methylphenidate. While initially effective, tolerance to the benefits may develop over time. Tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) may improve cataplexy.About 0.2 to 600 per 100,000 people are affected. The condition often begins in childhood. Men and women are affected equally. Untreated narcolepsy increases the risk of motor vehicle collisions and falls. The term "narcolepsy" is from the French narcolepsie. The French term was first used in 1880 by Jean-Baptiste-Édouard Gélineau, who used the Greek νάρκη (narkē), meaning "numbness", and λῆψις (lepsis) meaning "attack".

Browse All Tags